Patients whose tumours had high LIG1 nuclear expression had significantly poorer progression free survival (PFS) (p = 0.001) (Figure 1E) and overall survival (OS) (p = 0.037) (Figure 1F) compared patients with low LIG1 nuclear expressing tumours. Here, LIG1 is linked to neoplasm.